Protagenic Therapeutics, Inc.\new cotiza a 0.81 USD y tiene una capitalización bursátil de $1M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
| Periodo | 2022-04 | 2021-11 |
|---|---|---|
| Real | $-2.79 | $-2.80 |
| Estimado | $-2.80 | $-4.48 |
| Sorpresa | +0.4% | +37.5% |
| Métrica | PTIX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | 52.2% | -40.4% | +92.6% |
| ROA | 37.5% | -32.0% | +69.5% |
| Current Ratio | 1.50 | 2.84 | -1.34 |
| Debt / Equity | — | 0.28 | — |